GEOapplication/xmlftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE274nnn/GSE274838/primaryOK200TranscriptomicsHomo sapiensExpression profiling by arrayhttps://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE274838GEOGSEfalseMyeloablation Followed by Hematopoietic Stem Cell Transplantation and Long-Term Normalization of Systemic Sclerosis Molecular SignaturesThis is global gene expression study of whole blood samples collected in the Cyclophosphamide Or Transplantation (SCOT) randomized controlled trial, as well as unaffected controls. Patients with diffuse cutaneous systemic sclerosis (scleroderma) received either myeloablation followed by autologous stem cell transplantation or intravenous 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 sapiens